Fortress Biotech, Inc. Proceeds from Long-Term Debt Issued
Fortress Biotech, Inc. (FBIO) reported Proceeds from Long-Term Debt Issued of $33.72 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2024-11-14
- Fortress Biotech, Inc. proceeds from issuance of long-term debt for the quarter ending 2012-12-31 was $0.00.
- Fortress Biotech, Inc. proceeds from issuance of long-term debt for fiscal 2014 was $0.00.
- Fortress Biotech, Inc. proceeds from issuance of long-term debt for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Fortress Biotech, Inc. proceeds from issuance of long-term debt for fiscal 2012 was $15.00M.
- Fortress Biotech, Inc. proceeds from issuance of long-term debt for fiscal 2011 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 75 month | Proceeds from Issuance of Long-term Debt 90 month |
|---|---|---|---|---|---|
| 2024-09-30 | $33.72M 10-Q · filed 2024-11-14 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | ||||
| 2014-12-31 | $0.00 10-K · filed 2015-03-16 | ||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 | $15.00M 10-K · filed 2014-03-14 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $15.00M 10-K · filed 2015-03-16 | |||
| 2012-09-30 | $15.00M 10-Q · filed 2012-11-14 | $15.00M 10-Q · filed 2012-11-14 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |